Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Tatiana Nikulina"'
Autor:
Aleksina Shatilova, Larisa Girshova, Daniil Zaytsev, Irina Budaeva, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Tatiana Nikulina, Dmitriy Motorin, Darina Zammoeva, Svetlana Efremova, Vladimir Ivanov, Alexey Petukhov, Yuliya Alekseeva, Andrey Zaritskey
Publikováno v:
BMC Women's Health, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Myeloid sarcoma (MS) is a very rare condition, develops both in patients with other hematological neoplasms, and as isolated tumor. MS of the gynecologic tract is extremely rare. An available literature data about diagnosis and ma
Externí odkaz:
https://doaj.org/article/e22e3e6b95754c38a975215774eb3796
Autor:
Aleksandr Khudiakov, Daria Kostina, Anna Zlotina, Tatiana Nikulina, Alexey Sergushichev, Alexandra Gudkova, Alexey Tomilin, Anna Malashicheva, Anna Kostareva
Publikováno v:
Stem Cell Research, Vol 24, Iss C, Pp 77-80 (2017)
Human iPSC line was generated from patient-specific adipose tissue-derived mesenchymal multipotent stromal cells carrying desmin (DES) gene heterozygous splice site mutation using non-integrative reprogramming method. Reprogramming factors OCT4, KLF4
Externí odkaz:
https://doaj.org/article/45f0b317b1c54f84a10dff71d781ba17
Autor:
Irina Budaeva, Aleksina Shatilova, Dmitrij Motorin, Vladimir Ivanov, Konstantin Bogdanov, Yuliya Mirolyubova, Tatiana Nikulina, Ksenia Levchuk, Alina Ershova, Yuliya Alekseeva, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S222-S223
Autor:
Aleksina Shatilova, Irina Budaeva, Dmitriy Motorin, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Tatiana Nikulina, Yuliya Matvienko, Alina Ershova, Sergei Smirnov, Yuliya Alekseeva, Iurii Osipov, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S135
Autor:
Irina Budaeva, Aleksina Shatilova, Dmitrij Motorin, Vladimir Ivanov, Konstantin Bogdanov, Yuliya Mirolyubova, Tatiana Nikulina, Ksenia Levchuk, Alina Ershova, Yuliya Alekseeva, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S130
Autor:
Aleksina Shatilova, Irina Budaeva, Dmitriy Motorin, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Tatiana Nikulina, Yuliya Matvienko, Alina Ershova, Sergei Smirnov, Yuliya Alekseeva, Iurii Osipov, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S246
Autor:
Yulia Mirolyubova, Daniil Zaytsev, Alexey Petrov, Tatiana Nikulina, Konstantin Bogdanov, Elena Tochenaya, Andrey Zaritskey, Renat Badaev, Dmitriy Motorin, Irina Budaeva, V. E. Ivanov, Alexina Shatilova, Yulia Alekseeva, Larisa Girshova, R.I. Vabishchevich
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S301
Context: Treatment of patients with relapsed and refractory AML who are not candidates for intensive treatment is an actual problem. Objective: Assess the efficacy of gemtuzumab ozogamicin (GO) in combination with azacitidine; assess factors impactin
Autor:
Irina Budaeva, Daniil Zaytsev, Alexina Shatilova, Elena Tochenaya, Alexey Petrov, Raisa Vabishchevich, Dmitriy Motorin, Renat Badaev, Vladimir Ivanov, Konstantin Bogdanov, Yulia Mirolyubova, Tatiana Nikulina, Yulia Alekseeva, Andrey Zaritskey, Larisa Girshova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S216
Autor:
Aleksina Shatilova, Larisa Girshova, Daniil Zaytsev, Irina Budaeva, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Tatiana Nikulina, Dmitriy Motorin, Darina Zammoeva, Svetlana Efremova, Vladimir Ivanov, Alexey Petukhov, Yury Osipov, Yuliya Alekseeva, Andrey Zaritskey
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S211
Autor:
Daria Kostina, Anna Kostareva, Alexey Tomilin, A Gudkova, Anna Zlotina, Alexey Sergushichev, Tatiana Nikulina, Aleksandr Khudiakov, Anna Malashicheva
Publikováno v:
Stem Cell Research, Vol 24, Iss C, Pp 77-80 (2017)
Human iPSC line was generated from patient-specific adipose tissue-derived mesenchymal multipotent stromal cells carrying desmin (DES) gene heterozygous splice site mutation using non-integrative reprogramming method. Reprogramming factors OCT4, KLF4